PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease by Dumont, Vincent et al.
THE
JOURNAL • RESEARCH • www.fasebj.org
PACSIN2 accelerates nephrin trafficking and is
up-regulated in diabetic kidney disease
Vincent Dumont,* Tuomas A. Tolvanen,* Sara Kuusela,* Hong Wang,* Tuula A. Nyman,†,1 Sonja Lindfors,*
Jukka Tienari,*,‡ Harry Nisen,§ Shiro Suetsugu,{ Markus Plomann,k Hiroshi Kawachi,# and Sanna Lehtonen*,2
*Department of Pathology and †Institute of Biotechnology, University of Helsinki, Helsinki, Finland; ‡Department of Pathology, Helsinki
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ABSTRACT: Nephrin is a core component of podocyte (glomerular epithelial cell) slit diaphragm and is required for
kidney ultrafiltration.Down-regulation ormislocalization of nephrin has been observed in diabetic kidney disease
(DKD), characterized by albuminuria. Here,we investigate the role of protein kinaseC and casein kinase 2 substrate in
neurons 2 (PACSIN2), a regulator of endocytosis and recycling, in the trafficking of nephrin anddevelopment ofDKD.
Weobserve that PACSIN2 isup-regulated andnephrinmislocalized inpodocytes of obeseZuckerDiabetic Fatty (ZDF)
rats thathavealtered renal function. In culturedpodocytes, PACSIN2andnephrin colocalize and interact.Weshowthat
nephrin is endocytosed in PACSIN2-positive membrane regions and that PACSIN2 overexpression increases both
nephrin endocytosis and recycling. We identify rabenosyn-5, which is involved in early endosome maturation and
endosomal sorting, as a novel interaction partner of PACSIN2. Interestingly, rabenosyn-5 expression is increased in
podocytes inobeseZDFrats, and, invitro, itsoverexpressionenhances theassociationofPACSIN2andnephrin.Wealso
showthatpalmitate,which iselevated indiabetes, enhances thisassociation.Collectively,PACSIN2 isup-regulatedand
nephrin is abnormally localized in podocytes of diabetic ZDF rats. In vitro, PACSIN2 enhances nephrin turnover
apparently via a mechanism involving rabenosyn-5. The data suggest that elevated PACSIN2 expression accelerates
nephrin trafficking and associates with albuminuria.—Dumont, V., Tolvanen, T. A., Kuusela, S., Wang, H., Nyman,
T. A., Lindfors, S., Tienari, J., Nisen, H., Suetsugu, S., Plomann, M., Kawachi, H., Lehtonen, S. PACSIN2 accelerates
nephrin trafficking and is up-regulated in diabetic kidney disease. FASEB J. 31, 000–000 (2017). www.fasebj.org
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Diabetic kidney disease (DKD), the renal complication of
diabetes, accounts for 44% of all end-stage renal disease
cases requiring renal transplantation in the United States
(1). DKD occurs after decades of diabetes and is
characterized by persistent albuminuria and declined
glomerular filtration rate (GFR). The mechanisms un-
derlying DKD are not fully elucidated, but injury of
glomerular epithelial cells (podocytes) is involved.
Podocytes participate in the ultrafiltration of plasma into
urine together with the glomerular basement membrane
(GBM) and endothelial cells. Podocytes are highly spe-
cialized cells, and their foot processes interdigitate with
adjacent podocytes. The foot processes are connected by
special cell-cell junctions called slit diaphragms.Nephrin
is a key protein of the slit diaphragm, in which it func-
tions both structurally and via its signaling capacity
[reviewed by New et al. (2)]. Mutations in the nephrin
gene, NPHS1, induce severe kidney failure due to ex-
pression of a truncated form of nephrin or defective
trafficking of mutated nephrin to the plasma membrane
(3, 4). Similarly, amutation inNPHS2, encodingpodocin,
prevents efficient targeting of nephrin to the plasma
membrane (5), where nephrin normally locates in cav-
eolin-1–positive lipid rafts (6). This also results in de-
fective renal function, which shows that localization of
nephrin at the slit diaphragm is crucial.
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In DKD models, nephrin often appears to be down-
regulated (7, 8) ormislocalized (9). Nephrin participates in
controlling the structure of podocyte foot processes and
actin cytoskeleton via phosphorylation of its key tyro-
sine residues [reviewed by New et al. (2)]. Therefore,
controlled trafficking of nephrin, and the subsequent
coordinated signaling via nephrin, is essential for podo-
cytes and glomerular permselectivity. Nephrin in-
ternalization occurs via clathrin-mediated endocytosis
(CME) or the lipid raft pathway, one of the clathrin-
independent endocytosis (CIE) pathways (10, 11). The
choice between the pathways might be critical for glo-
merular function because the endocytic pathways have
different dynamics and therefore apparently different im-
pacts on nephrin signaling (11). However, the mecha-
nisms underlying the trafficking of nephrin after its
internalization remain largely unknown.
Protein kinase C and casein kinase 2 substrate in
neurons 2 (PACSIN2), also known as syndapin II, is a
member of the Bin-Amphiphysin-Rvs (BAR) family that
contains an evolutionary membrane binding and
sculpting domain. Specifically, PACSIN2 has an F-BAR
domain, which induces negative curvature to mem-
branes, and NPFmotifs and an SH3 domain that bind to
cytoskeletal, endocytic and recycling proteins (12, 13,
14). In kidney, PACSIN2 is expressed in tubules, where
it participates in repair processes after ischemia-
reperfusion injury (15). PACSIN2 is also present in
podocytes (15), yet its function has remained uncharac-
terized. In this study, we investigate whether PACSIN2
regulates the trafficking of nephrin and whether PAC-
SIN2 expression changes in DKD.
MATERIALS AND METHODS
Cell culture and preparation of cell lysates
Wild-type mouse podocytes and podocytes stably over-
expressing nephrin were produced and maintained as de-
scribed inWasik et al. (16). Sodiumpalmitate (Sigma-Aldrich,
St. Louis, MO, USA) was conjugated to free fatty acid-free
bovine serum albumin (BSA) (Sigma-Aldrich) at a 3:1 molar
ratio at 37°C for 1–2 h. When specified, medium was sup-
plemented with 50 mM BSA-palmitate, and/or glucose con-
centration was increased from 25 to 40 mM. Similar
concentrations of BSA and/or mannitol were used as con-
trols. Cells were lysed in NP-40 or M-PER buffer (Thermo
Fisher Scientific, Waltham, MA, USA) supplemented with
inhibitors as previously described in Wasik et al. (16).
Metabolic measurements and tissue preparation of
ZDF rats
Lean and obese male ZDF-Leprfa/Crt rats were purchased
from Charles River Laboratories (Wilmington, MA, USA).
Blood glucose was determinedwith Elite Glucometer (Bayer,
Leverkusen, Germany). Serum and 24-h urine samples, col-
lected in metabolic cages, were analyzed at the Biochemical
Analysis Core for Experimental Research of the University of
Helsinki usingAdvia 1650 (Siemens,Munich, Germany). The
estimated GFR was calculated using the creatinine clearance
method following the formula CCr = (UCr 3 V )/PCr, where
CCr is creatinine clearance (ml/min), UCr is urine creatinine
(mg/ml), V is urine volume per min, and PCr is plasma cre-
atinine (mg/ml). The result was adjusted to the weight of the
rat. Glomerular fractions were isolated from kidney cortices
by graded sieving (17) and lysed in NP-40 buffer. Freshly
dissected kidney tissues were embedded in Tissue-Tek Op-
timum Cutting Temperature (OCT) compound (Sakura
Finetek, Torrance, CA, USA) or fixed in 10% formalin fol-
lowed by embedding in paraffin. The protocols were ap-
proved by the National Animal Experiment Board.
Human glomerular lysate preparation
Tissue was collected from the healthy part of the kidney from
nephrectomy samples. Glomeruli were isolated by graded siev-
ing with 425/250/150-mm sieves (Retsch, Haan, Germany) and
lysed in M-PER buffer for coimmunoprecipitation. The use of
human material was approved by The Hospital District of Hel-
sinki and Uusimaa Medical Ethical Committee.
Antibodies
The antibodies used are listed in Supplemental Table 1.
Immunoperoxidase staining
Immunoperoxidase staining was performed as described in
Wasik et al. (16), with an additional incubation at room
temperature for 1 h prior to incubation over night at +4°C
with anti-PACSIN2 IgG (P2P). Images of 15–24 glomeruli per
rat (n = 6–8 per group) were taken by a researcher blinded to
phenotype. Randomized images were scored from 0 (nega-
tive) to 5 (strong staining) by 2 researchers independently
blinded to phenotype.
Immunoblotting
Podocyte and glomerular lysates were used for analyzing PAC-
SIN2 (P2B), nephrin (Progen), and rabenosyn-5 expression levels
as described in Lehtonen et al. (18) followed by quantification
with the Odyssey Infrared Imaging System (Li-Cor Biosciences,
Lincoln, NE, USA).
Indirect immunofluorescence
Kidney cryosections or cultured podocytes were stained as de-
scribed inHeikkilä et al. (17). Sampleswereexaminedwith SP8or
SP8 X confocal microscopes (Leica, Wetzlar, Germany). For
nephrin granularity scoring, images of 8–10 glomeruli of 5–8 rats
per group were taken by a researcher who was blinded to phe-
notype. Randomized images were scored from 0 (smooth) to 5
(granular) by 2 researchers independently based on the overall
granularity of the nephrin staining, the presence of punctate ac-
cumulations, and the continuity of nephrin signal along the
GBM.
Transient overexpression and knockdown
Mouse PACSIN2 cDNA (13) was subcloned into flag-containing
pCMV-Tag2B (Stratagene; Agilent Technologies, Santa Clara,
CA) or eGFP-N1 (Takara, Kusatsu, Japan) vectors using BamH1
restriction sites. Rabenosyn-5-eGFP plasmid was purchased
from Addgene (Cambridge, MA, USA). Cells were transfected
usingLipofectamine 2000 (ThermoFisher Scientific) andused for
experiments after 48 h.
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Structured illumination microscopy
Podocytes overexpressing nephrin and PACSIN2-eGFP were
incubated in complete medium containing nephrin 5-1-6 IgG
conjugated with Attodye 647N (516-647N; see Supplemen-
tal Table 1) for 5 min, followed by surface-labeling with
516-647N on ice for 15 min and fixing with 4% para-
formaldehyde at room temperature for 15 min. Images were
acquired with a structured illumination microscopy system
connected to an Eclipse Ti-E inverted microscope (Nikon,
Tokyo, Japan) and the NIS-Elements advanced research
v.4.5 software (Nikon).
Proximity ligation assay
Proximity ligation assay (PLA) was performed as pre-
viously described [referred to as Duolink In Situ by Wasik
et al. (16)]. Single antibody reactions were used as negative
controls.
Total internal reflection fluorescence microscopy
Podocytes were plated on glass-bottomed dishes and in-
cubated in complete medium containing 516-647N. Images
were acquired with a total internal reflection fluorescence
(TIRF) microscopy system connected to an Eclipse Ti-E
inverted microscope (Nikon) and the NIS-Elements ad-
vanced research v.4.5 software (Nikon).
On/In-Cell Western assay
Podocytes overexpressing nephrin were grown on 96-well
plates and transfected with flag-PACSIN2 or empty vector.
For On-Cell Western assay (Li-Cor Biosciences), cells were
transferred onto ice and incubated with 5-1-6 IgG in PBS, 5%
fetal bovine serum for 15 min. Cells were fixed with 4%
paraformaldehyde at room temperature for 10 min, blocked
in blocking buffer (Rockland, Pottstown, PA, USA), and in-
cubated with IRDye 800 donkey anti-mouse IgG (Li-Cor
Biosciences) in 1:1 mixture of Rockland blocking buffer-PBS,
0.1% Tween-20. Nuclear marker DRAQ5 (Thermo Fisher
Scientific) was used for normalization. Detection and quan-
titation were performed with an Odyssey Infrared Imager
(Li-Cor Biosciences). For In-Cell Western assay, cells were
incubated with 5-1-6 IgG in complete medium for the in-
dicated time and transferred onto ice for 15 min to allow
binding of the antibody to nephrin newly exported to the
plasma membrane. Cells were then processed as in On-Cell
Western assaywith an additional permeabilizationwith 0.1%
Triton-X100 for 10 min.
Immunoprecipitation
Lysates were precleared with protein G-Sepharose (Thermo
Fisher Scientific) and incubated with anti-PACSIN2, anti-
rabenosyn-5 or purified rabbit IgG (Thermo Fisher Scientific)
for 16 h at 4°C. Immune complexes were bound to rabbit
TrueBlot beads (eBiosciences, San Diego, CA, USA), washed
with M-PER buffer, and analyzed by mass-spectrometry or
immunoblotted.
Protein identification by liquid
chromatography-tandem mass spectrometry
Protein samples were analyzed by gel electrophoresis liquid
chromatography-tandem mass spectrometry as previously de-
scribed (19). The liquid chromatography-tandem mass spec-
trometry data were searched with in-house Mascot through
ProteinPilot interface against the SwissProt database (UniProt;
http://www.uniprot.org/.
Statistical analysis
The statistical significance was calculated by either Mann-
Whitney U test when n , 10, or Student’s t test when n . 10,
using GraphPad v.6.02 software (GraphPad Software, La Jolla,
CA,USA).Bars in the figures showthemean, anderrorbarsshow
the SD.
RESULTS
PACSIN2 expression is elevated in podocytes
of obese and diabetic ZDF rats
To investigate whether PACSIN2 expression level is
changed in podocytes in DKD, we used Zucker Diabetic
Fatty (ZDF) rats, which develop severe diabetes and renal
defects (20). Eight-week-old ZDF rats served as amodel of
early loss of glomerular function, and 34-wk-old rats
served as a model of advanced renal failure. As expected,
the obese 34-wk-old ZDF rats displayed hyperglycemia,
TABLE 1. Metabolic and renal parameters of 8- and 34-wk-old ZDF rats
Variable
8-wk-old ZDF rat 34-wk-old ZDF rat
Lean (n = 7) Obese (n = 7) Lean (n = 8) Obese (n = 6)
Weight (g) 222 6 10 332 6 28*** 473 6 20 412 6 25***
Kidney weight (g) 1.04 6 0.06 1.49 6 0.12*** 1.73 6 0.12 2.55 6 0.46***
6 h fasting blood glucose (mM) 5.97 6 0.67 4.57 6 0.80** 5.80 6 0.72 30.97 6 3.29***,a
24-h urine excretion (g) 2.9 6 0.9 11.8 6 4.4*** 7.7 6 1.5 42.9 6 6.0***
24-h albumin excretion (mg) 55.0 6 29.3 1660 6 843*** 234 6 383 8336 6 1171***
Urine albumin (mg/dl)/creatinine
(g/dl) ratio
15.6 6 9.1 307.3 6 152.2*** 15.2 6 22.2 979.7 6 153.5***
Urea nitrogen (mM) 5.17 6 0.50 8.22 6 1.31*** 6.63 6 1.09 9.76 6 0.66**
Estimated GFR (ml/min/100 g) 0.274 6 0.048 0.209 6 0.021* 0.289 6 0.085 0.195 6 0.017*
aAt 34 wk of age, the blood glucose level exceeded the maximum value of the glucometer in 2 obese rats for which the maximal value of the
glucometer (33.3 mM) was given. *P , 0.05, **P , 0.01, ***P , 0.001.
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declined estimated GFR, and severe albuminuria com-
pared with lean controls (Table 1).
Analysis of kidney sections revealed elevated expres-
sion of PACSIN2 in glomeruli of both 8- and 34-wk-old
obese rats compared with lean controls (Fig. 1A–C). The
staining pattern of PACSIN2 was typical for podocytes,
surrounding the glomerular tuft, and particularly obvious
in glomeruli of obese 34-wk-old rats (Fig. 1A, arrows).
Western blotting of isolated glomeruli confirmed a trend
of increased PACSIN2 expression at 8 wk and 90% in-
crease at 34 wk in obese ZDF rats (Fig. 1D–F). Colocali-
zation of PACSIN2 and nephrin appeared extended in
glomeruli of 34-wk-old ZDF rats (Fig. 1G), supporting in-
creased expression of PACSIN2 in podocytes in DKD,
which is in line with the immunohistochemistry data in
Fig. 1A.Collectively, our findings indicate thatPACSIN2 is
Figure 1. PACSIN2 expression level is increased in podocytes of obese ZDF rats. A) Immunohistological staining for PACSIN2 in
kidney sections of lean and obese ZDF rats reveals elevated PACSIN2 levels in glomeruli of obese rats. Arrows pinpoint strong
staining in cells, which exhibit the typical localization of podocytes in the outer part of the glomerular tuft. B, C) Scoring of
PACSIN2 staining intensity in glomeruli of 8- (B) and 34–wk-old (C) ZDF rats, from 0 (negative) to 5 (strong staining). Each data
point represents the average score of all glomeruli (15–24) analyzed in each rat (n = 6–8). At both 8 and 34 wk, glomeruli of obese
rats showed elevated PACSIN2 staining compared with lean control rats. (D) Representative Western blot of PACSIN2 in lysates
prepared of glomeruli isolated from 3 individual rats per group. b-actin is used as a loading control. E, F) Quantification of Western
blots similar to D (n = 6–8 per group). A trend of increase in the expression of PACSIN2 is observed in the glomeruli of 8-wk-old obese
rats compared with lean control rats (E). The increase is significant in glomeruli of 34-wk-old obese rats (F). G) Immunofluorescence
staining reveals that at 34 wk, PACSIN2 and nephrin colocalize in the glomeruli of ZDF rats and that the colocalization appears
extended in obese rats compared with lean control rats. Scale bars, 50 mm. Ns, nonsignificant. *P , 0.05, **P , 0.01.
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up-regulated in podocytes of rats with diabetes and ad-
vanced renal defects.
Nephrin displays a granular localization in
glomeruli of obese ZDF rats, but its expression
level remains unchanged
Western blotting revealed no significant difference in the
expression level of nephrin in the glomeruli of 8- or 34-wk-
old rats (Fig. 2A–C). However, the smooth appearance of
nephrin staining as a continuous line along the GBM that
was observed in lean rats was altered in the glomeruli of
obese ZDF rats (Fig. 2D). Already at the age of 8 wk, ir-
regularities in the staining pattern of nephrin along the
GBM and occasional punctate accumulations were ob-
served (Fig. 2D). At the age of 34 wk, abnormalities were
clearer and more frequent, as a dotted line often replaced
the smooth nephrin staining along the GBM. Grading of
thegranularityofnephrin staining revealeda clear trendat
8 wk and a significant increase at 34 wk (Fig. 2E, F).
To define the nature of nephrin aggregates, we per-
formeddouble labelingsofnephrinwithvesicle trafficking
Figure 2. The expression level of nephrin in obese ZDF rats is unaffected, but its expression pattern becomes granular. A)
Representative Western blots of nephrin in glomerular lysates from lean or obese rats at 8 or 34 wk of age (n = 3 per group).
b-actin is used as a loading control. B, C) Quantification of immunoblots similar as in A (n = 6–8 per group). No difference in the
expression level of nephrin is observed in the glomeruli of either 8- (B) or 34-wk-old (B) groups. D) Immunofluorescence images
showing that in glomeruli of both 8- and 34-wk-old lean rats, the pattern of nephrin staining displays a smooth appearance with a
sharp lining of the GBM. In glomeruli of obese rats, the staining for nephrin is irregular (arrowheads) and granules are
occasionally observed (arrows). E, F) Scoring of the granularity of nephrin staining in glomeruli of 8- (E) and 34-wk-old (F) ZDF
rats, from 0 (smooth pattern) to 5 (granular pattern). Each data point represents the average score of all glomeruli (8–10)
analyzed in each rat (n = 5–8). At 8 wk, the granularity score of nephrin staining in glomeruli of obese rats is higher but did not
reach statistical significance (E). At 34 wk, granularity of nephrin staining is significantly higher in obese rats compared to lean
controls (F). Scale bars, 30 mm. Ns, nonsignificant. *P , 0.05.
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markers andslitdiaphragmproteins.Clathrinheavychain
was found to partially colocalize with nephrin-positive
punctate structures in glomeruli of obese 34-wk-old ZDF
rats (Supplemental Fig. 1A). No significant colocalization
of nephrin was observed with rab5, cathepsin D, or p62,
which are markers of early endosomes, lysosomes, and
autophagic cargo, respectively (Supplemental Fig.
1B–D). However, punctate accumulations of nephrin
colocalized with the slit diaphragm proteins CD2AP
and podocin, the latter showing a remarkably similar
granular pattern as nephrin (Supplemental Fig. 1E, F).
Collectively, in obese ZDF rats the expression pattern
of nephrin becomes aberrant, although its expression
level remains unchanged.
PACSIN2 and nephrin colocalize and interact
in vitro
Using podocytes stably overexpressing nephrin, we ob-
served that PACSIN2andnephrin colocalize at theplasma
membrane and on vesicles spread throughout the cyto-
plasm, including the leading edges and the perinuclear
area (Fig. 3A). This supports the hypothesis that PACSIN2
regulates several steps of nephrin trafficking. Next, we
conjugated anantibody targeting the extracellular domain
of nephrin (5-1-6 antibody) to a fluorophore, hereafter re-
ferred to as 516-647N. In podocytes overexpressing
PACSIN2-eGFP, a 5-min pulse coupled with surface la-
beling of nephrin with 516-647N followed by high-
resolution structured illumination microscopy confirmed
the colocalization of PACSIN2 and nephrin at the plasma
membrane and on early endocytic tubules (Fig. 3B,
arrowheads). Moreover, PLA showed that endogenous
PACSIN2 associates with nephrin (Fig. 3C).
PACSIN2 accelerates the trafficking of nephrin
To functionally assess whether PACSIN2 regulates neph-
rin endocytosis, we transiently overexpressed PACSIN2-
eGFP in podocytes stably overexpressing nephrin and
incubated the cells in complete medium containing 516-
647N.LiveTIRFmicrocopyvideos revealed thatnephrin is
internalized at large and stable or small and versatile
structures positive for PACSIN2-eGFP (Fig. 4A and Sup-
plemental Video 1). Additionally, nephrin endocytosis
was observed in areas devoid of PACSIN2-eGFP.We next
transiently overexpressed fluorescently tagged caveolin-1
and clathrin light chain (CLC) in podocytes over-
expressing nephrin and incubated podocytes with 516-
647N for 20 min prior to fixation. TIRF microscopy
revealed that nephrin occasionally colocalizes with both
caveolin-1–DsRedmonomer and CLC-eGFP (Supple-
mentalFig. 2).This indicates thatnephrin ispresent inboth
caveolin-1– and CLC-positive coated pits and suggests
that it can be internalized via both CME and CIE. Also,
colocalization of caveolin-1 and CLC with PACSIN2
supports that PACSIN2 regulates both CIE and CME
(Supplemental Fig. 2).
To evaluate whether PACSIN2 regulates the presence
of nephrin at the plasma membrane, we transiently over-
expressed flag-PACSIN2 in podocytes overexpressing
nephrin. PACSIN2 overexpression doubled the level of
endogenous PACSIN2without affecting the expression of
nephrin (Supplemental Fig. 3A–C). On-CellWestern assay
Figure 3. PACSIN2 colocalizes and associates with nephrin. A) Confocal microscopy shows colocalization of PACSIN2 and
nephrin at the plasma membrane and on intracellular vesicles (arrowheads). B) High-resolution structured illumination
microscopy of podocytes overexpressing PACSIN2-eGFP and pulsed with 516-647N for 5 min before surface labeling and fixation.
Arrowheads indicate colocalization PACSIN2-eGFP and nephrin. C) Duolink PLA reveals that PACSIN2 and nephrin interact in
mouse podocytes. PLA performed with nephrin 5-1-6 IgG alone is shown as a negative control. Total signal on microscope fields
(n = 8), each containing 10–32 podocytes, was used for statistical analysis. Scale bars: 10 mm (A, B), 25 mm (C). ***P , 0.001.
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revealed that overexpression of flag-PACSIN2 reduced
the amount of nephrin inserted at the plasma mem-
brane by 65% (Fig. 4B). Next, we knocked down
PASCIN2 using short interfering RNA. This increased
the amount of nephrin inserted at the plasma mem-
brane by 87% (Supplemental Fig. 3F), confirming that
Figure 4. PACSIN2 enhances nephrin endocytosis and turnover. A) Live-cell TIRF microscopy analysis of podocytes
overexpressing PACSIN2-eGFP and incubated with 516-647N reveals that nephrin undergoes endocytosis in PACSIN2-
eGFP–positive spots. Arrowheads point to nephrin molecules which are internalized at either large and stable (magenta), or
small and versatile (blue) PACSIN2-eGFP-positive spots. Arrowheads point at nephrin entering the cell in areas devoid of
PACSIN2-eGFP. B) On-Cell Western analysis shows that overexpression of flag-PACSIN2 decreases the amount of nephrin
inserted at the plasma membrane (nwell = 33–34). The results are expressed as arbitrary units, representing the intensity of
nephrin staining normalized to the amount of cells measured using DRAQ5 staining intensity. C) In-Cell Western analysis
indicates that both empty-vector and flag-PACSIN2 overexpressing podocytes have higher levels of nephrin stained after 60 min
of incubation with the antibody followed by 15 min incubation on ice compared with the 15-min incubation on ice only (0 min),
(nwell = 36). D) The ratio of nephrin stained at 60 and 0 min presented in C reveals that nephrin turnover at the plasma
membrane is higher in flag-PACSIN2 overexpressing podocytes compared with empty vector -transfected cells. Each data point
represents the average of a single experiment (n = 3) in C. Scale bar, 2 mm. *P , 0.05, ***P , 0.001.
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PACSIN2 regulates the amount of nephrin present at
the plasma membrane.
The reduction of nephrin at the plasma membrane ob-
served in flag-PACSIN2–overexpressing podocytes could
bedue either to increasedendocytosis of nephrin or slower
delivery of nephrin to the plasma membrane. To distin-
guish between these options, we used an In-Cell Western
assay approach in which 5-1-6 antibody was added to the
culture medium of podocytes overexpressing flag-
PACSIN2 or the empty vector for 0 or 60 min. Sub-
sequently, surface-bound and internalized nephrin was
detected as in On-Cell Western assay with an extra per-
meabilization step. At 0 min, less nephrin was detected in
flag-PACSIN2–overexpressing podocytes than in empty
vector–transfected cells (Fig. 4C), which is in line with Fig.
4B. Both empty vector– and flag-PACSIN2–transfected
podocytes showed a strong increase of nephrin staining
after 60 min (Fig. 4C), when slightly more nephrin was
detected in the flag-PACSIN2–overexpressing podocytes
compared with empty vector–transfected cells (+15%,
nonsignificant) (Fig. 4C). This rules out the possibility
that PACSIN2 overexpression prevents the delivery of
nephrin to the plasma membrane. Strikingly, the ratio
of stained nephrin at t60/t0, reflecting the increase of
stained nephrin between 0 and 60 min, was signifi-
cantly higher in flag-PACSIN2–overexpressing cells
compared with empty vector–transfected cells (Fig.
4D). The significant increase in nephrin staining ob-
served at 60 min suggests that internalized nephrin
recycles back to the plasma membrane. This was con-
firmed by nephrin recycling assay (Supplemental Fig.
3G, H). Collectively, the data demonstrate that PAC-
SIN2 overexpression accelerates both the endocytosis
and recycling of nephrin, thereby enhancing nephrin
turnover at the plasma membrane.
Rabenosyn-5 interacts with PACSIN2 and is
up-regulated in podocytes of diabetic rats
To define the mechanisms by which PACSIN2 regu-
lates nephrin trafficking, we searched for novel in-
teraction partners of PACSIN2 inwild-type podocytes
by immunoprecipitation of endogenous PACSIN2
followed by “shot-gun”mass spectrometry approach.
Among the proteins identified, rabenosyn-5 (Mascot
score, 45; P , 0.05) raised our interest because it has
been shown to regulate the rate of endosomal recycling
(21). Reciprocal coimmunoprecipitations confirmed
that rabenosyn-5 and PACSIN2 form a complex in
mouse podocytes overexpressing nephrin (Fig. 5A)
and isolated human glomeruli (Fig. 5B). Also, nephrin
was observed in the precipitates, although its amount
was fairly low (Fig. 5A, B). Western blotting revealed
that the expression level of rabenosyn-5 was increased
by 1.8- and 2.5-fold in glomeruli of obese ZDF rats
compared with lean controls at both 8 and 34 wk, re-
spectively (Fig. 5C–E). Immunofluorescence micros-
copy indicated an increase in rabenosyn-5 levels in
glomeruli of 34-wk-old obese ZDF rats, and the ex-
pression pattern suggested an increase in podocytes
and other glomerular cells (Fig. 5F).
Overexpression of rabenosyn-5 increases the
association of nephrin with PACSIN2
Next, we overexpressed PACSIN2-eGFP or rabenosyn-
5-eGFP in podocytes stably overexpressing nephrin
followed by staining for endogenous rabenosyn-5 or
PACSIN2, respectively. PACSIN2-eGFP appears to
colocalize occasionally with both nephrin and rabenosyn-
5 on intracellular vesicles all over the cytoplasm, con-
centrating close to the plasma membrane and in the
perinuclear area (Fig. 6A). Interestingly, overexpression of
rabenosyn-5-eGFP led to a more vesicular localization
pattern of PACSIN2 and nephrin in the juxtanuclear re-
gion and appeared to enhance the colocalization of the 3
proteins (Fig. 6B). To confirm this observation, we quan-
tified the interactionbetweennephrin andPACSIN2using
PLA and found that the association of the 2 proteins in-
creased by 90% in rabenosyn-5-eGFP–overexpressing
podocytes compared with cells transfected with eGFP
alone (Fig. 6C, D). The increase in complex formation is
specific because neither PACSIN2 nor nephrin expression
level was affected by rabenosyn-5-eGFP overexpression
(Supplemental Fig. 4).
Palmitate enhances the association of nephrin
with PACSIN2
To characterize which diabetes-associated circulating fac-
tor increases the associationof PACSIN2withnephrin and
therebypotentially enhances the traffickingof nephrin,we
treated podocytes with high glucose, palmitate, or a
combination of the two and measured the association of
nephrin and PACSIN2 by PLA. High glucose alone
(40 mM, 48 h) did not increase the association of nephrin
with PACSIN2. On the other hand, treatment of podo-
cytes for 48 h with 50 mM palmitate enhanced their as-
sociation by 27% and enhanced the combination of high
glucose and palmitate by 32% (Fig. 7). The increase in
complex formation was not due to increased expression
of PACSIN2 or nephrin (Supplemental Fig. 5).
DISCUSSION
Despite intensive efforts, regulation of nephrin trafficking
has remained unclear. Here, we demonstrate that the
F-BAR protein PACSIN2 enhances nephrin endocytosis
and recycling back to the plasma membrane. This appar-
ently relies on the newly identified protein complex con-
taining nephrin, PACSIN2 and rabenosyn-5, here
identified in cultured podocytes and human glomeruli.
Moreover, the formation of the PACSIN2-nephrin com-
plex is enhanced by palmitate treatment.
PACSIN2 decreases the amount of nephrin at the
plasma membrane, suggesting a role for PACSIN2 in
nephrin endocytosis (Fig. 4). This is supported by the
presence of PACSIN2-eGFP andnephrin on endocytic pits
and early endosomal tubules (Figs. 3 and 4 and Supple-
mental Fig. 2). These results corroborate the ideas raised in
previous studies, suggesting that nephrin endocytosis
occurs via both CME and CIE (10, 11, 22, 23) and that
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PACSIN2 regulates both CME and CIE (13, 14, 24). In-
terestingly, protein kinase C a (PKC-a), up-regulated in
diabetic glomeruli (22, 23), is known to directly phos-
phorylate both nephrin and PACSIN2 (22, 23, 25). PKC-
a–mediated phosphorylation of nephrin regulates its
internalization (23), and the phosphorylation of PACSIN2
by PKC-a regulates caveolae-mediated endocytosis (25).
Thus, PKC-a could be a major regulator of nephrin traf-
ficking in diabetic conditions by a mechanism potentially
involving PACSIN2. The fact that PKC-a deletion pre-
vented the loss of nephrin expression in experimental
DKD (26) further supports a role for PKC-a in the loss of
kidney function in diabetes by regulating nephrin ex-
pression and trafficking. Taken together, our TIRF mi-
croscopy results and the results from previous studies
demonstrate that nephrin internalization is complex and
may occur via various pathways, some of which involve
PACSIN2. The entry of nephrin into the cell may depend
onwhethernephrin is damagedor engaged in signalingor
whether the glomeruli need to adapt to varying hemo-
dynamic conditions.
Our study provides evidence that a significant amount
of nephrin traffics back to the plasma membrane after in-
ternalization (Supplemental Fig. 3). This is in line with the
idea that nephrin and other slit diaphragm components
have a high turnover rate (27). We also show that PAC-
SIN2 regulates not only endocytosis but also recycling of
nephrin; both processes are necessary for accelerated
turnover of nephrin at the plasmamembrane (Fig. 4). This
is supportedbycolocalizationofPACSIN2withnephrin in
various intracellular locations (Fig. 3). Previous studies
show that PACSIN2 localizes to early/sorting endosomes
(EE/SE), tubular recycling endosomes, and the Golgi
complex (28, 29). The novel interaction of PACSIN2 with
rabenosyn-5 further supports a role for PACSIN2 in the
recycling of nephrin. Rabenosyn-5 functions in EE/SE
maturationandendosomal recyclingasan effector ofRab5
andRab4 (21, 30).Overexpressionof rabenosyn-5hasbeen
Figure 5. Rabenosyn-5 interacts with PACSIN2 and is increased in glomeruli of obese ZDF rats. A) Western blot showing that
PACSIN2 and rabenosyn-5 coimmunoprecipitate in lysates of mouse podocytes overexpressing nephrin. Nephrin is also detected
in PACSIN2 immunoprecipitations (IP). B) Western blot indicating that PACSIN2, rabenosyn-5 and nephrin coimmunopre-
cipitate in lysates of isolated human glomeruli. C) Representative Western blot of rabenosyn-5 in glomerular lysates from 3
individual rats per group. b-actin is included as a loading control. D, E) Quantification of the Western blots similar as in C (n =
6–8 per group). A 1.5-fold increase in the expression of rabenosyn-5 is observed in the glomeruli of 8 wk old rats and a 2.7-fold
increase at the age of 34 wk (D) compared with lean controls (E). F) Immunofluorescence staining for rabenosyn-5 and nephrin
in kidney sections of ZDF rats reveals that at 34 wk, the expression of rabenosyn-5 is increased in various glomerular cell types,
including podocytes (arrowheads). Scale bars, 30 mm. *P , 0.05, **P , 0.01.
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shown to increase the size of the EE/SE compartment and
to enhance the association of Rab4 and Rab5 and the
recycling rate of transferrin (21). In podocytes with en-
dogenous levels of rabenosyn-5, PACSIN2, nephrin, and
rabenosyn-5 rarely colocalize (Fig. 6), suggesting that the
interaction of the 3 proteins is transient in normal condi-
tions (Figs. 5 and 6). However, overexpression of
rabenosyn-5 attracted nephrin and PACSIN2 onto juxta-
nuclear vesicular structures and enhanced their associa-
tion (Fig. 6). Further studies are required to characterize
the interplay and shared function of PACSIN2 and
rabenosyn-5 in podocytes. Previous work suggests that
PACSIN2 is necessary for nucleation and scission of tu-
bular recycling endosomes from rabenosyn-5–positive
EE/SE (28, 31). Thus, their cooperation at the surface of
endosomal membranes could contribute to changing the
nature of maturing endosomes. Nonetheless, our results
demonstrate a role for PACSIN2 in the recycling of
nephrin, with a mechanism apparently involving
rabenosyn-5. A role of rabenosyn-5 in the trafficking of
nephrin could explain albuminuria observed in a patient
who carries a mutated form of rabenosyn-5 (32).
In podocytes of obese and hyperglycemic ZDF rats,
elevated expression of PACSIN2 and rabenosyn-5 is
associated with a granular pattern of nephrin and severe
albuminuria (Figs. 1, 2, and 5 and Table 1). The punctate
structures positive for nephrin were occasionally also
positive for clathrin heavy chain, highlighting a potential
role for endocytosis in the pathophysiological changes
occurring in podocytes in diabetic conditions. Previous
electron microscopy studies reported that podocytes of
obese ZDF rats present vacuolization and droplets and
have an increased capacity for endocytosis (33, 34). We
observed that endocytosednephrinwasnot trapped in the
endolysosomal system (Supplemental Fig. 2), but the
punctate structures stained with antibodies against
nephrin were also positive for CD2AP, which regulates
intracellular trafficking in podocytes (35) and anchors the
slit diaphragm to the cytoskeleton by binding actin di-
rectly (36). Strikingly, podocin, which escorts newly syn-
thesizednephrin to theplasmamembrane (5), also showed
extensive colocalization with nephrin on the punctate
structures (Supplemental Fig. 2). Therefore, one can spec-
ulate that podocin participates in the trafficking of nephrin
in both health and disease, and that in diabetes the traf-
ficking is aberrant, leading to the formation of vacuoles
and aggregates. Protein and fat droplets have also been
observed inpodocytesof obeseZucker rats (37), amodelof
Figure 6. Rabenosyn-5 colocalizes with PAC-
SIN2 and nephrin and increases their associa-
tion. A) PACSIN2-eGFP overexpressed in
podocytes colocalizes with rabenosyn-5 and
nephrin near the plasma membrane (arrow)
and on intracellular vesicles (arrowheads). B)
Rabenosyn-5-eGFP overexpressed in podocytes
colocalizes with PACSIN2 and nephrin at the
cell edge (arrow) and on large juxtanuclear
vesicles (arrowheads). C) PLA of PACSIN2 and
nephrin in empty vector-eGFP and rabenosyn-
5-eGFP overexpressing podocytes. D) Quantifi-
cation of PLA signal as in (C) in individual
podocytes overexpressing empty vector-eGFP
or rabenosyn-5-eGFP (n = 103–106). Scale bars,
25 mm. ***P , 0.001.
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diabetes fromwhich the ZDF rats originate. Interestingly,
a recent study observed granular localization of nephrin
and podocin in a protamine sulfate–induced podocyte
effacement model (38), suggesting that abnormal traf-
ficking of nephrin, along with podocin, is not limited to
diabetes. It may be that in situations requiring fast glo-
merular adaptation, such as in diabetes and protamine-
sulfate model, an increase in the turnover of the slit
diaphragm proteins may lead to the saturation of the
trafficking machinery, resulting in improper sorting
and creation of aggregates containing nephrin and
possibly other slit diaphragm components.
Palmitate, which is the most abundant free fatty acid
(39), is elevated in the circulation of patients with insulin-
resistantdiabetes (40). Strikingly, bothpalmitate aloneand
in combination with high glucose led to an increase in the
association of nephrin andPACSIN2 (Fig. 7).Highglucose
alone did not enhance the PACSIN2-nephrin association,
possibly because a 48-h treatment was not long enough to
mimic the constitutive metabolic pressure occurring in
diabetes in vivo. This may also explainwhy the treatments
did not change PACSIN2 expression level. Interestingly,
palmitate enhances the activity of mTORC1 in podocytes
(41), and constitutive activation of mTORC1 leads to ab-
errant localization of nephrin (9), reminiscent of the gran-
ular pattern of nephrin that we observed in ZDF rats.
Previously, most studies have analyzed the expression
level rather than the localization of nephrin in DKD and
typically reported lower levels (7, 8, 26) or even up-
regulation of nephrin (42). These discrepancies may be
explainedby thedifferentmodels andmethodsusedor the
stage of disease analyzed.
In diabetes, glomeruli are subjected to hemodynamic
stress (43), and podocytes must adapt to changing intra-
glomerular pressure tomaintain the covering of the GBM.
Thus, it is possible that up-regulation of PACSIN2 and
rabenosyn-5 represents an adaptivemechanism aiming to
maintain the integrity of the glomerular filtration barrier
by increasing endocytosis and turnover of the slit di-
aphragm components, nephrin in particular. However, it
remains to be analyzedwhether PACSIN2 accelerates this
turnover in vivo andwhether accelerated trafficking of the
slit diaphragm components prevents or worsens the de-
velopment of DKD.Nonetheless, PACSIN2may associate
with renal pathophysiology, as suggested by our study
and others. Indeed, PACSIN2 expression is elevated in
proximal and collecting tubules in a model of ischemia-
reperfusion injury, reflecting a potential role in tubulo-
genesis (15). In tubular cells, PACSIN2 also interacts with
polycystin-1, which is mutated in polycystic kidney dis-
ease, further supporting a role for PACSIN2 in the main-
tenance of renal function (44).
In summary, we show here that PACSIN2, nephrin,
and rabenosyn-5 form a complex in podocytes and pro-
pose that PACSIN2 fastens up the endocytosis and in-
tracellular traffickingofnephrinbyamechanism involving
rabenosyn-5. The elevated expression of PACSIN2 and
rabenosyn-5 observed in DKD could reflect an attempt to
adapt to the hemodynamic and metabolic stress, both
deleterious for renal function.
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Supplemental Figure legends 
 
Supplemental Figure S1. Nephrin colocalizes with podocin, CD2AP and occasionally with 
clathrin but not with rab5, cathepsin D or p62 in the punctate structures in the ZDF rat 
glomeruli 
(A-F) Double immunofluorescence staining of glomeruli of 34 wks old obese ZDF rats with 
nephrin and (A) clathrin heavy chain, (B) rab5, (C) cathepsin D, (D) p62, (E) CD2AP or (F) 
podocin. The antibodies used are listed in Supplemental Table S1. Scale bars: 50 µm.  
 
Supplemental Figure S2. Nephrin and PACSIN2 colocalize at the plasma membrane with 
caveolin-1 and occasionally with clathrin light chain 
(A-D) TIRF microscopy analysis of podocytes overexpressing clathrin light chain-eGFP (A, C) 
or caveolin-1-DsRedmonomer (B, D), and PACSIN2-mCherry (C) or PACSIN2-eGFP (D). In 
(A) and (B), podocytes were incubated in the presence of 516-647N for 20 min prior to fixation. 
TIRF microscopy reveals that nephrin and PACSIN2 colocalize regularly with caveolin-1 and 
occasionally with clathrin light chain (arrowheads). Mouse PACSIN2-mCherry and caveolin-1-
DsRedmonomer were described in (1). Clathrin light chain-eGFP was subcloned into pEF-BOS 
vector as in (1). Scale bar: 10 µm. 
 
Supplemental Figure S3. PACSIN2 knockdown increases the insertion of nephrin at the 
plasma membrane. A significant amount of internalized nephrin is recycled back to the 
plasma.  
(A) Western blot showing overexpression of flag-PACSIN2 in podocytes. β-actin is used as a 
loading control. (B, C) Quantification of Western blots similar as in (A) reveals a 2-fold increase 
of PACSIN2 (B) without affecting nephrin levels (C). (D) Western blot of mouse podocyte 
lysates after transfection of scrambled or PACSIN2 siRNAs. (E) Quantification of Western blots 
similar as in (D) reveals that PACSIN2 siRNA-treatment decreased the level of PACSIN2 by 
59%. (F) On-Cell Western analysis shows that knockdown of PACSIN2 increases the amount of 
nephrin inserted at the plasma membrane (nwell=54). Mouse podocytes expressing nephrin were 
transfected with ON-TARGET plus SMARTpool mouse PACSIN2 (L-045093-01-0005) or 
siCONTROL Non-Targeting Pool#2 (D-001206-14-05) siRNAs (Dharmacon, Lafayette, CO) 
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using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) 16 h after plating and used for experiments 
after 48 h. (G, H) To confirm that internalized nephrin is recycled back to the plasma membrane, 
we performed qualitative immunofluorescence (G) and quantitative On-Cell Western (H) control 
experiments in which we added the 5-1-6 IgG to the culture medium of podocytes for 30 min, 
allowing internalization of IgG-labeled nephrin molecules. Thereafter, cells were acid stripped 
(1,15% acetic acid, 0.5 M NaCl, 4 min on ice) to remove the IgG bound to nephrin molecules 
still present at the plasma membrane, followed by incubation in culture medium without 5-1-6 
IgG for 0-120 min to allow recycling of nephrin. Finally, a fluorescently labeled secondary IgG 
was applied without permeabilization to stain nephrin that was recycled back to the plasma 
membrane. With this approach, we observed that a significant amount of labeled, internalized 
nephrin was recycled back to the plasma membrane, reaching a peak of 15% 30 min after 
stripping (Supplemental Figure S3G, H). The nuclear marker DRAQ5 (ThermoFisher) was used 
for normalization in (H). In (H, nwell=33-54), * and # indicate that the statistical test was 
performed against no stripping or 0 min, respectively. Scale bar: 40 µm. Bars show the mean and 
error bars the standard deviation. The statistical analysis compares the mean of single wells from 
three experiments combined using Student’s t-test. #p<0.05, **/##p<0.01, ****/####p<0.0001 
 
Supplemental Figure S4. Rabenosyn-5-GFP overexpression does not change the expression 
level of nephrin or PACSIN2 
(A) Western blot of rabenosyn-5-GFP overexpressing podocytes. β-actin is included as a loading 
control. (B-D) Quantification of Western blots similar as in (A) shows a 75% increase of total 
rabenosyn-5 (B) without affecting nephrin (C) or PACSIN2 (D) levels. Bars show the mean and 
error bars the standard deviation. Statistical significance is calculated using Mann-Whitney-U 
test. **p<0.01; ns, nonsignificant  
 
Supplemental Figure S5. High glucose or palmitate do not change the expression levels of 
PACSIN2 and nephrin after 48 h treatment. 
(A-C) Western blot of PACSIN2 and nephrin in podocytes treated with high glucose (A), 
palmitate (B) or both (C), as well as their respective controls. α-tubulin is included as a loading 
control. (D-E) Quantification of Western blots similar as in (A-C). Bars show the mean and error 
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bars the standard deviation. Statistical significance is calculated using Mann-Whitney-U test. ns, 
nonsignificant  
 
Supplemental Table S1. List of antibodies used in the study. 
The 5-1-6 IgG (3) was fluorescently labeled with NHS-ester Attodye 647N (Siegen, Germany), 
referred to as 516-647N. 
Primary IgGs 
  Antigen Host   Company/Sup. Reference 
alpha-tubulin mouse   Sigma-Aldrich, St. Louis, MO, USA 
beta-actin mouse   Sigma-Aldrich 
cathepsin D rabbit   Novus Biologicals, Littleton, CO, USA 
CD2AP rabbit   (2) 
clathrin heavy chain mouse   Calbiochem, San Diego, CA, USA 
nephrin guinea pig   PROGEN Biotechnik, Heidelberg, Germany 
nephrin "5-1-6" mouse   (3) 
p62 guinea pig   PROGEN 
PACSIN2 "P2B" rabbit   Abgent, San Diego, CA, USA 
PACSIN2 "P2P" rabbit   (4) 
podocin rabbit   Sigma-Aldrich 
rab5 rabbit   Cell Signaling Technology,Danvers, MA, USA 
rabenosyn-5 rabbit   (5) 
   
Secondary IgGs 
  Antigen Host   Company/Sup. Reference 
Alexa Fluor 594-anti rabbit donkey   Molecular Probes, Eugene, OR, USA 
Alexa Fluor 594-anti mouse donkey   Molecular Probes 
Alexa Fluor 488-anti mouse donkey   Molecular Probes 
Alexa Fluor 488-anti guinea pig donkey   Molecular Probes 
IRDye 800-anti mouse goat   LI-COR Lincoln, NE, USA 
IRDye 800-anti rabbit donkey   LI-COR Lincoln 
IRDye 680-anti mouse donkey   LI-COR Lincoln 
IRDye 680-anti guinea pig donkey   LI-COR Lincoln 
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Supplemental Video S1. Nephrin is internalized in PACSIN2-eGFP positive sites. 
Podocytes overexpressing PACSIN2-eGFP (green) and nephrin are incubated in the presence of 
516-647N IgG (red). TIRF microscopy is used to observe the endocytosis of nephrin. Time is 
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